Small Molecules, 'Green' Biotechnology
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
92
NCT03806478
Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 30, 2023
Completion: Dec 31, 2024
NCT03813095
Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction
Start: Oct 31, 2023
Completion: Dec 31, 2025
Loading map...